Phase II trial of epirubicin at standard dose in relapsed ovarian cancer-Reference-Cited by-同舟云学术

Phase II trial of epirubicin at standard dose in relapsed ovarian cancer

Published:1996-05 Issue:5 Volume:32 Page:899-900
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Peláez I.,Lacave A.J.,Palacio I.,Alvarez E.,Cueva J.F.,Muñiz I.,Arranz F.,Fra J.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference13 articles.

1. Second trial drugs in ovarian cancer;Stanhope;Gynecol Oncol,1977

2. Adriamycin therapy for advanced ovarian carcinoma recurrent after chemotherapy;Hubbard;Cancer Treat Rep,1978

3. Adriamycin in ovarian cancer patients resistant to cyclophosphamide;Bolis;Eur J Cancer,1978

4. A phase II study of epirubicin in advanced ovarian carcinoma;Tropé,1984

5. A phase II study of the effect of 4-epidoxorubicin, administered in high dose 150 mg/m2 in 24 hours intravenous infusion, in advanced ovarian carcinoma;Simonsen,1987

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicenter Phase 2 Study of Combined Gemcitabine and Epirubicin as Second-Line Treatment for Patients With Advanced Ovarian Cancer;International Journal of Gynecologic Cancer;2010-07

2. Liposome-encapsulated doxorubicin citrate in previously treated recurrent/metastatic gynecological malignancies;International Journal of Gynecologic Cancer;2007-01

3. Efficacy and tolerability of the ifosfamide-epirubicin combination in relapsed ovarian cancer;International Journal of Gynecological Cancer;2006-01

4. Part II: Chemotherapy for epithelial ovarian cancer-treatment of rcurrent disease;The Lancet Oncology;2002-09

5. Anthracyclines in the Treatment of Gynecologic Malignancies;Gynecologic Oncology;2002-04